Fenoldopam: Difference between revisions
(Created page with "==Administration== *Type: Antihypertensive, Dopamine agonist *Dosage Forms: 10 mg/mL (1 mL), 20mg/2 mL (2 mL) *Routes of Administration: Intravenous *Common Trade Names: Corlo...") |
|||
| Line 6: | Line 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
*Severe hypertension | *Severe hypertension: Initial 0.01 to 0.3 msg/kg/minute, increase incrementally 0.05 to 0.1 msg/kg/minute q 15 minute until target blood pressure is reached (maximum dose recorded in the study was 1.6 mcg/kg/minute), limit for up to 48-hour use. | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
*Severe hypertension: Initial 0.2 msg/kg/minute; increase incrementally 0.3 to 0.5 mcg/kg/minute q 20 to 30 minutes (maximum 0.8 mcg/kg/minute), limit for 4 hour use | *Severe hypertension: Initial 0.2 msg/kg/minute; increase incrementally 0.3 to 0.5 mcg/kg/minute q 20 to 30 minutes (maximum 0.8 mcg/kg/minute), limit for 4 hour use | ||
Revision as of 16:07, 20 June 2016
Administration
- Type: Antihypertensive, Dopamine agonist
- Dosage Forms: 10 mg/mL (1 mL), 20mg/2 mL (2 mL)
- Routes of Administration: Intravenous
- Common Trade Names: Corlopam
Adult Dosing
- Severe hypertension: Initial 0.01 to 0.3 msg/kg/minute, increase incrementally 0.05 to 0.1 msg/kg/minute q 15 minute until target blood pressure is reached (maximum dose recorded in the study was 1.6 mcg/kg/minute), limit for up to 48-hour use.
Pediatric Dosing
- Severe hypertension: Initial 0.2 msg/kg/minute; increase incrementally 0.3 to 0.5 mcg/kg/minute q 20 to 30 minutes (maximum 0.8 mcg/kg/minute), limit for 4 hour use
Special Populations
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: